Surgical or Exercise Therapy on Patients With Degenerative Meniscus Tears
Launched by OSLO UNIVERSITY HOSPITAL · Oct 26, 2009
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
The aims of the study are:
1. At 3 months, to investigate the effect of arthroscopic partial meniscectomy versus exercise therapy on muscle strength and knee function in middle-aged patients with degenerative meniscus lesions.
2. At 2 years, to investigate the effect of arthroscopic partial meniscectomy versus exercise therapy on self-reported outcomes in middle aged patients with degenerative meniscus lesions.
3. At 5 years, to describe radiographic changes in knee osteoarthritis development after arthroscopic partial meniscectomy or exercise therapy in middle-aged patients with degenerat...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 35-60 years
- • Knee pain for more than 2 months without a significant trauma
- • Medial meniscal tear on MRI
- • Eligible for arthroscopic partial meniscectomy
- • Grade 0-2 radiographic severity (specification after Kellgren Lawrence)
- Exclusion Criteria:
- • Those requiring acute trauma surgeries, including those treated as acute cases in the ER
- • Ligament injuries
- • Tumours (MRI)
- • Pain or other musculoskeletal comorbidities severely affecting lower extremity muscle function overriding the symptoms from the knee
- • Grade 3 or 4 radiographic severity (specification after Kellgren Lawrence)
- • Comorbidities excluding physical activities and exercise.
- • Previous knee surgery within two years
- • Not able to speak or read Norwegian, drug abuse or mental problems
About Oslo University Hospital
Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Oslo, , Norway
Patients applied
Trial Officials
May Arna Risberg, PT, PhD
Principal Investigator
Oslo University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials